|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02211 UNI HEALTH
Nominal 
0.160 +0.004 (+2.564%) | 2024/12 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Turnover | 441,153 | -25.398% | 1,089,037 | 1,297,036 | 1,273,572 | 1,185,168 |
| Cost of Sales | (370,790) | -25.117% | (909,152) | (1,083,190) | (1,069,410) | (1,028,264) |
| Gross Profit | 70,363 | -26.844% | 179,885 | 213,846 | 204,162 | 156,904 |
| 2024/12 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | (3,972) | |
| Change in FV & Impairment on Others | -- | -- | (4,157) | (10,098) | (21,579) | (214,489) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 339 | -48.792% | 1,733 | (20,959) | (1,625) | 3,220 | |
| Profit / (Loss) before Taxation | (5,887) | -73.837% | (2,792) | (112,105) | (188,013) | (670,804) | |
| Taxation | (1,793) | -- | 3,372 | 5,990 | 0 | (5,203) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (332) | 637.778% | (167) | 718 | 366 | 611 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (8,012) | -61.718% | 413 | (105,397) | (187,647) | (675,396) | |
| 2024/12 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Net Finance Costs / (Income) | (1,707) | -- | 4,607 | (7,278) | (2,322) | 10,615 |
| Depreciation & Amortisation | 6,874 | -3.278% | 14,030 | 16,235 | 26,055 | 108,920 |
| Directors' Emoluments | -- | -- | 2,025 | 2,388 | 2,675 | 2,481 |
| 2024/12 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/12 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| EPS (cts) | -1.000 | -68.153% | 0.060 | -18.070 | -42.660 | -174.830 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.152) | (0.031) | (0.096) | (0.279) |
| NBV per share ($) | 0.424 | -- | 0.440 | 0.471 | 0.734 | 1.488 |
| Remarks: | Real time quote last updated: 06/03/2025 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -8,012,000 |
| %Change | -61.718% |
| EPS / (LPS) | RMB -0.010 |
| NBV Per Share (¥) | RMB 0.424 |